The National Pharmaceutical Council (NPC) has announced that it will host a conference for health care stakeholders to discuss the effect of medical treatment on patient care and how the value of these treatments can be measured.
The conference, which will take place on Thursday, Sept. 29, is titled “Assessing Value: Promise and Pitfalls.”
"The tools and solutions we develop to move health care toward a system driven by value must be grounded in sound science and centered on the needs and values of patients," NPC President Dan Leonard said. "Well-structured value assessment frameworks that incorporate the full value and benefits of a medical innovation can help achieve this. It is critically important to get this right, and much work remains to be done before existing frameworks will be ready for broader use in the United States."
The field of value assessment is still new. With the progressions being made in this field, the possibility of it having an effect on deciding which courses of treatments patients receive looms large. This would undoubtedly affect coverage and reimbursements as well.
The transition to care that is centered around patients, incentive-based payment models and expensive therapies have created multiple assessment frameworks.